A Follow‐Up Investigation: In Vitro Effects of Kefir‐Derived Biomolecules on β‐Amyloid Aggregation
This study highlights the potential ability of kefir fractions and synthetic peptides to prevent and disrupt Aβ42 aggregation in vitro, supporting their therapeutic promise in neurodegenerative disorders. Further studies should explore their mechanisms of action and efficacy in vivo.
Authors
- Serena Mares Malta (ORCID: https://orcid.org/0000-0002-9330-9503)
- Ana Carolina Costa Santos (ORCID: https://orcid.org/0000-0003-1893-0743)
- Foued Salmen Espíndola (ORCID: https://orcid.org/0000-0002-6937-1411)
- Renata Graciele Zanon (ORCID: https://orcid.org/0000-0001-5930-3821)
- Tamíris Sabrina Rodrigues (ORCID: https://orcid.org/0000-0002-9778-6702)
- Carlos Ueira‐Vieira (ORCID: https://orcid.org/0000-0002-8369-9069)
- Matheus Henrique Silva (ORCID: https://orcid.org/0000-0002-7900-2927)
- Lucas Matos Martins Bernardes (ORCID: https://orcid.org/0009-0003-9250-5996)
- Ana Paula Mendes‐Silva
- Fernanda Araújo do Prado mascarenhas
- Letícia Leandro Batista
Institutions
- Johannes Gutenberg University Mainz (DE)
- University of Saskatchewan (CA)
- Universidade Federal de Uberlândia (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_103543
- Primary Topic
- Protein Hydrolysis and Bioactive Peptides
- Type
- article
- Field-Weighted Citation Impact
- 0.00